Background: Most studies of high-dimensional phenotypes focus on assessing differences in 2 mean levels (location) of the phenotype by exposure, e.g. epigenome-wide association studies 3 of the effect of exposure on mean DNA methylation at CpG sites. However, identifying 4 effects on the variability (scale) of these outcomes could provide additional insights into 5 biological mechanisms. 6
Introduction 1
Most investigations into health-related phenotypes have focused on determining whether an 2 exposure affects the mean of a phenotype (location test). However, assessing whether an 3 exposure affects the variability of a phenotype (scale test) could also provide insight into the 4 biological mechanisms that control phenotypic variation and disease pathogenesis as well as 5 identify possible interactions (1) (2) (3) . Furthermore, the potential of combining a location test 6 with a scale test has yet to be fully explored (joint location-and-scale test), especially in the 7 context of high-dimensional phenotypes where these tests could be used to improve power as 8 well as to identify markers involved in interactions (4). One example where these approaches 9 could be particularly useful is for epigenome-wide association studies (EWAS), where DNA 10 methylation at CpG (cytosine followed by a guanine) sites across the genome are tested for 11 association with an exposure (Supplementary Text) (5,6). 12 A range of statistical tests have been developed to test whether an exposure affects variability 13 of an outcome, specifically in the context of evaluating variability differences for a 14 continuous variable between groups of individuals (7). Li et al. (8) compared approaches for 15 assessing methylation variability in the EWAS setting, and showed that the Brown-Forsythe 16 test (9) performed well compared to alternative approaches. Since this test can be re-17 formulated in a regression framework (10,11), it can be extended to continuous exposures. 18
Methods for jointly testing mean and variability have also been proposed (4,10-15), although 19 these approaches are either limited by sensitivity to distributional assumptions or are 20 restricted to binary exposures. 21
Here, we introduce two approaches: an extension (to continuous exposures) of the Forsythe test of variability and a joint location-and-scale test, which can be used for both 23 continuous and categorical exposures. We performed a simulation study to compare these 24 4 approaches to alternative tests, and then applied these modelling approaches to investigate the 1 effect of gender and gestational age on cord blood DNA methylation mean and variability. 2 . OLS regression is known to be 9 relatively robust to the underlying assumptions related to the residuals when estimating the 10 regression coefficients (discussed further in the Supplementary Text). 11 12 There are several statistical tests for assessing variability differences of continuous outcome 13 by a categorical exposure (7). Bartlett's test (16) is perhaps the most well-known of these tests 14 (Supplementary Text) and has been applied in the EWAS setting (3, 17) . However, this test is 15 known to be very sensitive to outliers and non-normality of the outcome, which is a major 16 cause of concern when analysing DNA methylation. The Brown-Forsythe test (9), on the 17 other hand, is robust to non-normality of the outcome and outliers (8 can also be applied to continuous exposures. Indeed, this approach has the same structure as 8 the Glejser and Bresuch-Pagan tests of heteroskedasticity (18, 19) . 9 However, these tests are also sensitive to deviations from normality and outlying values (13). 18
Methods

Scale tests
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Joint location-and-scale tests
To alleviate some of the issues involved in testing for mean and variability effects 19 simultaneously, we have developed a joint location-and-scale score test (JLSsc). This 20 approach essentially combines a location test and scale test, while accounting for the 21 6 correlation between these tests. We propose to test the joint null hypothesis ‫ܪ‬ : 
. The estimator for the variance of 
Hence, the score test for ‫ܪ‬ :
Other covariates are regressed out of both the outcome and exposure variables by taking 1 residuals from OLS regression prior to analysis with JLSsc. Further details of JLSsc are 2 discussed in the Supplementary Text. 3
We have developed an R package to perform these tests available at: 4 https://github.com/jrs95/jlst. 5
Simulation study 6 We assessed the performance of the location and scale tests as well as the joint location-and-7 scale tests with both binary and continuous exposures in a simulation study. We assessed the 8 performance of OLS regression, Bartlett's test (for simulations with a binary exposure), 9
Brown-Forsythe test, LRT comparing mixed models with and without a variability effect 10 (LRTv), JLSsc, JLSp, LRTmv and DGLM. For approaches which failed to adequately control 11 type I error rates, we repeated the tests after applying an inverse normal rank transformation 12 to the methylation levels. This simulation study was performed based on data from the 13 Power simulations were performed using the same exposure distributions as above and setting 1 these exposures to affect the mean and variability of methylation. In each simulation replicate, 2 one CpG was selected at random from the Tsaprouni et al. dataset, the mean and standard 3 deviation of this CpG site were used to set the average methylation and to generate mean and 4 variability effects (Supplementary Text). The mean and variability effects of the exposure on 5 methylation were simulated using normal distributions, while the residual error was simulated 6 to be either normally distributed, heavy-tailed or skewed (Supplementary Text). We also 7 performed simulations for a categorical exposure with three categories and where we 8 Parents and Children (ALSPAC) (23,24). ALSPAC recruited 14 541 pregnant women with 20 expected delivery dates between April 1991 and December 1992. Of these initial pregnancies, 21 there were 14 062 live births and 13 988 children who were alive at 1 year of age. Please note 22 that the study website contains details of all the data that is available through a fully searchable data 23 dictionary and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/). Ethical 24 approval for the study was obtained from the ALSPAC Ethics and Law Committee and the 25 9 Local Research Ethics Committees. Informed consent for the use of data collected via 1 questionnaires and clinics was obtained from participants following the recommendations of 2 the ALSPAC Ethics and Law Committee at the time. Consent for biological samples has been 3 collected in accordance with the Human Tissue Act (2004). 4
As part of the Accessible Resource for Integrated Studies (ARIES) project 5 (http://www.ariesepigenomics.org.uk) (25), a sub-sample of 1018 ALSPAC child-mother 6 pairs had DNA methylation measured. The ARIES participants were selected based on 7 availability of DNA samples at two time-points for the mother (antenatal and at follow-up 8 when the offspring was in adolescence) and at three time-points for the offspring (neonatal 9 from cord blood, childhood (age 7) and adolescence (age 17)). 10
Laboratory methods, quality control and pre-processing 11 The laboratory methods and quality control procedures used have been described elsewhere 12 (26). In brief, the DNA methylation wet laboratory and pre-processing analyses were 13 performed at the University of Bristol as part of the ARIES project, where the Infinium 14 HumanMethylation450 BeadChip (27) was used to measure genome-wide DNA methylation 15 levels at over 485 000 CpG sites. The methylation level at each CpG site was calculated as a 16 beta value: the ratio of the methylated probe intensity and the overall intensity. These beta 17 values range from 0 (no methylation) to 1 (complete methylation). The samples were 18 processed using functional normalization with the meffil package (28,29). Further quality 19 control procedures are described in the Supplementary Text. 20
Statistical analysis 21
To investigate the mean and variability effects of gender and gestational age (in weeks, 22
Supplementary Text) on cord blood methylation, we used the approaches which controlled 23 type I error rates without transforming methylation levels, namely OLS regression, the 24 1 using the method described by de Goede et al. for cord blood methylation (30) . We further 2 adjusted for 20 surrogate variables to account for residual batch effects (31). The gestational 3 age analysis was further adjusted for offspring gender and whether the birth was by caesarean 4 section as well as for maternal characteristics: age, smoking, pre-pregnancy BMI and weight, 5 parity, education, family social class and alcohol intake during pregnancy. CpGs were 6 considered to be associated with either gender or gestational age if one of the location, scale 7 or joint tests had
All analyses were performed using R (version 3.5.2). 9
Results
10
Simulation study 11 OLS regression test of mean differences was not inflated under the null of no mean or 12 variability effect even in 100 samples (Figures 1a and S1) . Similarly, the Brown-Forsythe 13 variability test accurately controlled type I error rates (Figures 1b and S2 ). Bartlett's test and 14
LRTv had extreme type I error inflation due to the deviations from normality and the 15 existence of outlying values in methylation levels ( Figure S3) . Likewise, the test statistics 16 from the likelihood-based approaches for joint testing the mean and variability (LRTmv and 17 DGLM) were also heavily inflated ( Figure S3 ). The extreme inflated type I error rates of these 18 approaches were no longer present after transforming methylation levels using an inverse 19 normal rank transformation ( Figure S4 ). However, when using this transformation a mean 20 effect can induce a variability effect and vice versa ( Figure S5 ), as seen previously (32). JLSp 21 fared better than the aforementioned joint tests in controlling type I error rates, although the 22 non-independence of the ‫‬ -values did lead to a small amount of type I error inflation ( Figure  23 1c and Figure S6 ). The JLSsc approach, on the other hand, correctly controlled type I error 1 rates (Figure 1d and Figure S6 ). 2
In the power simulations, when there was either a mean or variability effect and the 3 underlying data were normally distributed, the Brown-Forsythe test and JLSsc were less 4 powerful but still performed well in comparison to the equivalent LRT and the alternative 5 approaches (Figure 2 ). This is expected as the Brown-Forsythe test and JLSsc sacrifice a 6 small amount of power under the normal model for robustness to deviations from this model. 7
Broadly similar results were found when the residual error was heavy-tailed or skewed, when 8 the exposure was a categorical variable with three categories and when there was an outlier in 9 the dataset ( Figures S7-S10) . 10
The computational time required to complete each approach for 100 000 CpGs with a binary 11 exposure were as follows: 22 minutes for the extended Brown-Forsythe test, 113 minutes for 12
LRTv, 16 minutes for JLSsc and 123 minutes for LRTmv. The relative computation times 13 between the respective variability and joint tests were even greater when the exposure was 14
continuous. 15
Application to gender and gestational age to 16 In ARIES, 858 children (417 male and 441 female) were available for the analysis of gender, 17
and after excluding offspring with missing maternal information we were left with 708 18 children (345 males and 363 females) for the analysis of gestational age (mean: 39.5 weeks, 19 standard deviation: 1.5 weeks; Table S1 ). 20
Methylation at 8174 CpG sites were associated with gender in cord blood (through the mean, 21 variability or joint tests; Figure 3a and Table S2 ). Most of these sites were identified through 22 a mean difference in methylation of males and females (7642 CpGs had a mean difference 23 with ‫‬ ൏ 1 ൈ 1 0 ି ), although 240 CpG sites were associated with a variability difference 24 between males and females. For instance, cg18918831 was more variable in males compared 1 to females (Figure 4a ). The joint location-and-scale tests identified 7724 of these CpG sites 2 (JLSp identified 7213 sites and JLSsc identified 7228 sites), including all of those with a 3 variability effect. Mean methylation at 5359 of these sites were associated with gender in 4 previous EWAS (Table S2 ) (33-36). 5
Gestational age was associated with cord blood methylation at 412 CpG sites (Figure 3b and 6 Table S3 ). Most of these CpG sites were associated with a mean effect of gestational age on 7 methylation, and there were no CpG sites with a variability effect with
The 8 joint mean and variability tests identified 93.7% of the CpG site associations (JLSp identified 9 317 and JLSsc identified 340 CpG sites, respectively), including sites that were mostly 10 identified through a variability association (e.g. cg24577594; Table S3 ). The majority of the 11 CpG sites identified have been found previously in EWAS of gestational age (402 CpG sites; 12 Table S3 ) (36, 37) . 13
Discussion
14
In this study, we have introduced a framework for testing variability using an extended 15 version of the Brown-Forsythe test and for jointly testing mean and variability. These 16 approaches were compared to the LRTs as well as other alternative methods in simulations 17 and were used to investigate the effect of gender and gestational age on cord blood DNA 18
methylation. 19
Without transforming the methylation levels to be normally distributed, the approaches which 20 assume normality of the phenotype (Bartlett's test, LRTv, LRTmv and DGLM) had extremely 21 inflated type I error rates when faced with real methylation data. Indeed, these approaches 22 essentially became tests of deviations from normality and outlying values, which can have 23 some utility in identifying outliers caused by disease (38). However, because of these 24 13 drawbacks these approaches are not useful for assessing variability nor joint mean and 1 variability effects, especially as normalizing outcome levels to overcome this problem can 2 induce effects that were not present prior to the transformation (32). The extended Brown-3 Forsythe test and the JLSsc approach retained correct type I error rates and performed well in 4 comparison to the other approaches in detecting variability and joint effects. These tests were 5 also at least 5 times more efficient than their LRT counterparts. 6
Over 8000 CpG sites were associated with gender in cord blood methylation, while 7 methylation at 412 CpG sites were associated with gestational age. The majority of these CpG 8 sites were associated with effects of gender and gestational age on mean methylation. 9
However, 240 CpG sites were associated with differences in variability between males and 10 females. JLSsc identified most of the associations in both analyses, except where there was 11 little evidence of a mean/variability effect in the presence of a borderline effect of the other. 12
These methods are applicable to any area of medical research where variability and joint 13 effects are of interest, although they will be particularly useful for analysing high-dimensional 14 phenotypes where it is not possible to assess the distribution at all markers. For instance, there 15 has been recent interest in using variability tests to attempt to identify gene-environment 16 interactions, as these interactions will often cause heterogeneity in the variance across 17 genotypes (4,32). The Brown-Forsythe test has been proposed as a useful test in this scenario 18 (32), although the extended version presented here and elsewhere (10,11) could be used to 19 assess variability trends across genotypes. Furthermore, JLSsc avoids the distributional 20 assumptions made by current methods proposed in the genetics literature (4,10,11). 21
The limitations of this study also warrant consideration. In the simulations and the applied 22 example, only categorical variables with two-levels were assessed in detail, although we fully 23 expect these results to reasonably extend to categorical variables with many categories. The 24 application of the approaches to detect CpG sites associated with gender and gestational age 25 computer and laboratory technicians, clerical workers, research scientists, volunteers, 1 managers, receptionists and nurses. 2 
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